Biomarin Pharmaceutical Inc Revenue per Employee (BMRN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biomarin Pharmaceutical Inc  (NASDAQ: BMRN)
 

Biomarin Pharmaceutical Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 32.02% in the third quarter 2026, year on year to cumulative value of $3,655 million, Biomarin Pharmaceutical Inc's revenue per employee grew on a trailing twelve months basis to $ 1,134,780, this is below the company average.
Within the Healthcare sector Employees of 76 other companies have achieved higher revenue per employee. While Biomarin Pharmaceutical Inc's total ranking has deteriorated compared to the previous quarter from 344 to 851. Biomarin Pharmaceutical Inc has 3,221 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMRN Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 32.02 % 19.91 % 2.83 % 17.03 % 4.08 %
Sales per Employee (TTM) $ 1,134,780 1,057,626 1,006,618 1,000,079 960,572
BMRN's Total Ranking # 851 # 344 # 802 # 136 #
Seq. Revenue Change 3.53 % 29.17 % -12.39 % 12.68 % -5.97 %

BMRN Company Profile >> Back to BMRN Efficiency Comparisons >> Compare BMRN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 54
Healthcare Sector # 77
Overall Market # 851

Revenue per Employee Statistics
High Average Low
$ 1,057,626 $ 472,992 $ 124,424
(Jun 30 2026)   (Mar 31 2011)



Financial Statements
Biomarin Pharmaceutical Inc's Revenue MRQ $ 1,025 Millions Visit BMRN's Income Statement
Biomarin Pharmaceutical Inc's Revenues TTM $ 3,655 Millions Visit BMRN's aggregate revenue growth
What are BMRN's Sales? Visit BMRN's Sales by Segment




Other Ratios
Biomarin Pharmaceutical Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BMRN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BMRN's Competitors
Revenue per Employee for BMRN's Suppliers
Revenue per Employee for BMRN's Customers

You may also want to know
BMRN's Sales Growth Rates BMRN's Pe Price to earnings ratio BMRN's Receivables Turnover Ratio BMRN's Stock Quote
BMRN's Net Income Growth Rates BMRN's Ps Price to Sales ratio BMRN's Sales per Employee BMRN's Asset Turnover Ratio
BMRN's Net Margin BMRN's Pb Price to Book ratio BMRN's Financial Strength Ratios BMRN's Dividend Payout Ratio
Date modified: 2026-11-04T10:10:28+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.